ArticleMolecular biology reports2026
Inflammatory response and immunological alteration in polycystic ovary syndrome: An integrative case-control study.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPolycystic ovarian syndrome (PCOS) is a prevalent endocrine condition affecting females of reproductive age with low-grade inflammation; however, the relationship between the immune system and PCOS remains unidentified.
objectiveOur study aimed to investigate the association between inflammation-mediated and immune-modulating molecules in women with PCOS and to highlight their potential roles and interactions in mediating chronic low-grade inflammation.
methods90 Iraqi women were involved in a case-control study, aged between 18 and 45 years, divided into pairs of groups, first one group of 50 women who had been recently diagnosed with PCOS according to Rotterdam criteria, and 40 apparently healthy women. Serum concentrations of Cyclooxygenase-2 (COX2), Prostaglandin E2 (PGE2), Human Leukocyte Antigen Type-G (HLA-G), Heat Shock Protein 70 (HSP70), Gonadotropin-Releasing Hormone (GnRH), Anti-Müllerian Hormone (AMH), and Estradiol (E2) were estimated using standard immunoassays. Statistical analysis was performed to compare groups and assess the association between biomarkers and clinical features.
resultsOur results showed higher levels of AMH, GnRH, COX2, PGE2, HLA-G, and HSP70 in PCOS women compared to women without PCOS. Alongside women with PCOS, the E2 concentration showed no significant difference from that in the control group. For COX2, PGE2, and HSP70, the area under the curve (AUC) was 1.000. For HLA-G, the AUC was 0.964.
conclusionThe findings suggest that inflammatory mediators and immune-regulatory molecules are associated with the inflammatory and immunological alterations observed in PCOS, providing additional insights into the underlying biological mechanisms. Further studies are warranted to validate their potential clinical utility.
Indexed as
Identifiers
42536282What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.